A Method to Fluorescently Label the CRISPR/Cas9-gRNA RNP Complexes Enables Enrichment of Clinical-Grade Gene-Edited Primary Hematopoietic Stem Cells and iPSCs

被引：0

|

作者：

Nasri, Masoud ^{[1
]}

Mir, Perihan ^{[1
,2
]}

Dannenmann, Benjamin ^{[1
]}

Amend, Diana ^{[1
]}

Xu, Yun ^{[1
]}

Solovyeva, Anna ^{[1
]}

Stefanczyk, Sylwia ^{[1
]}

Klimiankou, Maksim ^{[1
]}

Zeidler, Cornelia ^{[3
]}

Kanz, Lothar ^{[4
]}

Welte, Karl ^{[5
]}

Skokowa, Julia ^{[1
,2
]}

机构：

[1] Univ Hosp Tuebingen, Dept Oncol Hematol Immunol Rheumatol & Pulmonol, Tubingen, Germany

[2] German Canc Res Ctr, Heidelberg, Germany

[3] Hannover Med Sch, SCNIR, Hematol Oncol, Hannover, Germany

[4] Univ Hosp Tuebingen, Tubingen, Germany

[5] Univ Childrens Hosp Tuebingen, Tubingen, Germany

来源：

BLOOD | 2018年 / 132卷

关键词：

D O I：

10.1182/blood-2018-99-114844

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1108

引用

收藏

页数：2

相关论文

共 3 条

[1] Aryl Hydrocarbon Receptor Antagonists Expand Adult Hematopoietic Stem Cells From Mobilized Peripheral Blood and Bone Marrow and Increase the Dose of CRISPR/Cas9 Gene-Edited NSG-Repopulating Cells
Hoban, Megan D.
Goncalves, Kevin A.
Proctor, Jennifer L.
George, Katia S.
Adams, Hillary L.
Hyzy, Sharon L.
Boitano, Anthony E.
Cooke, Michael P.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S423 - S423
[2] Aryl Hydrocarbon Receptor Antagonists Expand Adult Hematopoietic Stem Cells from Mobilized Peripheral Blood and Bone Marrow and Increase the Dose of CRISPR/Cas9 Gene-Edited NSG-Repopulating Cells
Hoban, Megan D.
Goncalves, Kevin A.
Proctor, Jennifer L.
Adams, Hillary L.
Hyzy, Sharon L.
George, Katia S.
Boitano, Anthony E.
Cooke, Michael P.
BLOOD, 2017, 130
[3] A Novel Aryl Hydrocarbon Receptor Antagonist Expands Adult Human Hematopoietic Stem Cells from Mobilized Peripheral Blood and Bone Marrow and Increases the Dose of CRISPR/Cas9 Gene-Edited NSG-Repopulating Cells
Hoban, Megan D.
Goncalves, Kevin A.
Proctor, Jennifer L.
George, Katia S.
Adams, Hillary L.
Hyzy, Sharon L.
Boitano, Anthony E.
Cooke, Michael P.
MOLECULAR THERAPY, 2019, 27 (04) : 453 - 454